GlassScriptPhysician profile
Thomas Rashid
NPI 1992762892
$12,287.31
in general payments reported to CMS, 2019-2025
48 companies · $3,926 in 2025
The $3,926 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.81 · 2020: $631 · 2021: $1,645 · 2022: $2,107 · 2023: $2,223 · 2024: $1,743 · 2025: $3,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,064 · Honoraria: $1,785 · Education: $43.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,064.34 |
| Honoraria | $1,785.00 |
| Education | $43.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $1,921.82 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $1,371.29 | 2020-2025 | Xtandi, Veozah |
| Janssen Biotech, INC. | $1,204.67 | 2021-2025 | Erleada |
| Abbvie INC. | $975.85 | 2020-2025 | |
| Boston Scientific Corporation | $746.75 | 2020-2025 | Moses, Lumenis Pulse 120h, Ams 800 Artificial Urinary Sphincter |
| Sumitomo Pharma America, INC. | $736.13 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $708.24 | 2020-2025 | Speedicath, Porges Coloplast |
| Pfizer INC. | $485.98 | 2020-2025 | |
| Procept Biorobotics Corporation | $445.89 | 2020-2025 | Aquabeam Robotic System, Aquabeam System |
| Antares Pharma, INC. | $444.29 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Teleflex LLC | $370.57 | 2020-2025 | Barrigel, Urolift |
| Urovant Sciences INC | $293.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $190.53 | 2021-2025 | Lynparza, Keytruda |
| Immunitybio, INC. | $189.95 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $179.49 | 2020-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $173.27 | 2021-2024 | Prolaris, Myrisk |
| Novartis Pharmaceuticals Corporation | $144.83 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $143.49 | 2023-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $136.49 | 2025 | Provenge |
| Accord Healthcare, INC. | $132.00 | 2023-2025 | |
| Medtronic, INC. | $126.34 | 2022-2025 | Interstim |
| Endo USA, INC. | $104.53 | 2024-2025 | Xiaflex |
| Ethicon US, LLC | $95.19 | 2020-2023 | Echelon; Endopath, Surgiflo Hemostatic Matrix, Stratafix |
| Endo Pharmaceuticals INC. | $85.59 | 2021-2023 | Xiaflex, Aveed |
| Conmed Corporation | $79.71 | 2023 | Airseal |
| Halozyme INC | $79.36 | 2023 | |
| Clarus Therapeutics INC. | $76.71 | 2021 | |
| Ferring Pharmaceuticals INC. | $76.46 | 2024-2025 | Adstiladrin |
| Tolmar, INC. | $67.66 | 2023-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $61.45 | 2021-2025 | Posluma |
| Myovant Sciences INC. | $59.87 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $45.88 | 2024 | Trelstar |
| Travere Therapeutics, INC. | $40.82 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Photocure INC | $32.99 | 2025 | Cysview |
| Caldera Medical, INC | $32.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.48 | 2025 | |
| Caris Mpi, INC. | $29.37 | 2025 | Mi Cancer Seek |
| Cook Medical LLC | $24.22 | 2020 | |
| Laborie Medical Technologies Corp. | $17.36 | 2023 | |
| Palette Life Sciences, INC. | $17.00 | 2022 | |
| Telix Pharmaceuticals | $14.32 | 2024 | Illuccix |
| Allergan, INC. | $13.91 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $12.44 | 2021 | |
| Olympus America INC. | $11.81 | 2019 | |
| Neotract INC. | $11.81 | 2020 | |
| Convatec INC. | $11.19 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rashid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.